No Detail Found!

m6A RNA, FTO, ALKBH5 Expression in Type 2 Diabetic and Obesity Patients

Author(s)
Erhan Onalan Department of Internal Medicine, Firat University, Medical School,Elazig,Turkey
Burkay Yakar Department of Family Medicine, Firat University, Medical School,Elazig,Turkey
Ebru Etem Onalan Department of Medical Biology, Firat University, Medical School,Elazig,Turkey
Koray Karakulak Department of Internal Medicine, Firat University, Medical School,Elazig,Turkey
Tugce Kaymaz Department of Medical Biology, Firat University, Medical School,Elazig,Turkey
Emir Donder Department of Internal Medicine, Firat University, Medical School,Elazig,Turkey
Abstract
Objective: To investigate whether m6A content changes in type 2 diabetes mellitus (T2DM) and obese individuals and whether the relationship of m6A content with the mRNA expression levels of FTO and ALKBH5 genes. Study Design: Cross-sectional study. Place and Duration of Study: Department of Internal Medicine, Firat University, Medical School, Elazig, Turkey, between January 2019 and January 2022. Methodology: The study included 34 newly diagnosed patients with type 2 diabetes mellitus, 34 obese individuals, and 33 healthy individuals without any chronic and metabolic disease matched for age and gender. The global m6A RNA methylation, FTO, and ALKBH5 gene analyses of all the participants were performed. Total cholesterol, triglyceride, LDL, HDL, HbA1c, and insulin and glucose levels were measured. 6 Results: The median percentages of mA RNA methylation in the control group, obese, and T2DM participants were 5.62%, 4.20%, and 5.21% respectively (p=0.004). The m6A RNA methylation percentage of the obese participants was signi cantly lower than controls (p=0.021). The FTO andALKBH5 mRNA levels were signi cantly lower in obese and T2DM participants than in controls. There was a negative signi cant correlation between 6Am RNA level and FTOi.e. (r=-0.291, p=0.003) andALKBH5 (r=-0.321. p=0.001) levels. 6 Conclusion: m A RNA expression levels of obese individuals were lower than healthy controls.The FTO and ALKBH5 mRNA expressions were lower in both obese and T2DM participants compared to the healthy controls. There was no signi cant di erence between obese and T2DM individuals in terms of m A RNA expression, FTO and ALKBH5 mRNA expression. m6A RNA expres6 sion, FTO, and ALKBH5 levels have a potential role in obesity and diabetes mellitus.
Publication Details
Page(s) 1143-1148
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 32, Issue: 9, Year: 2022

Request the full text from PASTIC

Keywords
genetic, m6A RNA methylation, Epigenesis, FTO, ALKBH5
0

Citations

0

Downloads

78

Views